drug
RTX-015
Phase 3updated 6mo agoby Ray Therapeutics Inc
Phase 3community read0 votes
all catalysts(0)
nothing on the calendar yet
Trials studying RTX-015
News(1)
- Fierce Biotech Fundraising Tracker '26: China's Eli Radiopharma raises $60M; Neurosterix notches $105MThe Fierce Biotech Fundraising Tracker records venture capital rounds of $50 million or more secured by biotechs.fiercebiotech · 11mo ago
Data sources
last refreshed 5h ago
Found something off?
comments(0)
5-min edit window · permanent after that